JENBURKT PHARMACEUTICALS
Back to Income Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹152 Cr | ₹142 Cr | ₹137 Cr | ₹124 Cr | ₹109 Cr |
What is the latest Revenue of JENBURKT PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹152 Cr |
| Mar2024 | ₹142 Cr |
| Mar2023 | ₹137 Cr |
| Mar2022 | ₹124 Cr |
| Mar2021 | ₹109 Cr |
How is Revenue of JENBURKT PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹152 Cr | 6.85 | |
| Mar2024 | ₹142 Cr | 3.82 | |
| Mar2023 | ₹137 Cr | 10.30 | |
| Mar2022 | ₹124 Cr | 13.44 | |
| Mar2021 | ₹109 Cr | - | |
Compare Revenue of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹491.2 Cr | -0.9% | -1% | -14.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -0.9% |
-1% |
-14.6% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses